Skip to main content

Peer Review reports

From: A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders

Original Submission
11 Mar 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
22 Mar 2013 Author responded Author comments - Ahmad Ghanizadeh
Resubmission - Version 3
22 Mar 2013 Submitted Manuscript version 3
18 May 2013 Author responded Author comments - Ahmad Ghanizadeh
3 May 2013 Reviewed Reviewer Report - Helmut Niederhofer
6 May 2013 Reviewed Reviewer Report - Thomas Frazier
Resubmission - Version 4
18 May 2013 Submitted Manuscript version 4
2 Jul 2013 Author responded Author comments - Ahmad Ghanizadeh
12 Jun 2013 Reviewed Reviewer Report - Helmut Niederhofer
28 May 2013 Reviewed Reviewer Report - Thomas Frazier
Resubmission - Version 5
2 Jul 2013 Submitted Manuscript version 5
9 Jul 2013 Reviewed Reviewer Report - Thomas Frazier
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
24 Jul 2013 Editorially accepted
25 Jul 2013 Article published 10.1186/1471-244X-13-196

You can find further information about peer review here.

Back to article page